Literature DB >> 9253703

Fungaemia due to Fusarium spp. in cancer patients.

V Krcmery1, Z Jesenska, S Spanik, J Gyarfas, J Nogova, R Botek, J Mardiak, J Sufliarsky, J Sisolakova, M Vanickova, A Kunova, M Studena, J Trupl.   

Abstract

Five cases of fungaemia due to Fusarium spp. in cancer patients are described. Two were breakthrough cases, despite ongoing therapy with amphotericin B. Three were caused by Fusarium solani, one by F. oxysporum and one by F. dimerum. Four patients died, three of them despite therapy with amphotericin B for between 5-37 days. We describe only the second reported case of F. dimerum fungaemia. Since 1972, 93 cases of systemic infection with Fusarium spp. have been described: 43 had positive blood cultures and the overall mortality was 72%.

Entities:  

Mesh:

Year:  1997        PMID: 9253703     DOI: 10.1016/s0195-6701(97)90197-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment.

Authors:  Ning Zhang; Kerry O'Donnell; Deanna A Sutton; F Ameena Nalim; Richard C Summerbell; Arvind A Padhye; David M Geiser
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.

Authors:  Vladimír Buchta; Alena Feuermannová; Martin Váša; Lenka Bašková; Radka Kutová; Alena Kubátová; Marcela Vejsová
Journal:  Mycopathologia       Date:  2014-01-01       Impact factor: 2.574

4.  Specific detection of fusarium species in blood and tissues by a PCR technique.

Authors:  F X Hue; M Huerre; M A Rouffault; C de Bievre
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  Assessment of genotyping markers in the molecular characterization of a population of clinical isolates of Fusarium in Colombia.

Authors:  Valeria Velásquez-Zapata; Katherine Palacio-Rúa; Luz E Cano; Adelaida Gaviria-Rivera
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

6.  CYP51 Mutations in the Fusarium solani Species Complex: First Clue to Understand the Low Susceptibility to Azoles of the Genus Fusarium.

Authors:  Pierre Vermeulen; Arnaud Gruez; Anne-Lyse Babin; Jean-Pol Frippiat; Marie Machouart; Anne Debourgogne
Journal:  J Fungi (Basel)       Date:  2022-05-20

7.  Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel.

Authors:  Ran Nir-Paz; Jacob Strahilevitz; Mervyn Shapiro; Nathan Keller; Anna Goldschmied-Reouven; Oded Yarden; Colin Block; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  PCR - RFLP patterns for the differentiation of the Fusarium species in virtue of ITS rDNA.

Authors:  R Kachuei; M H Yadegari; N Safaie; A Ghiasian; F Noorbakhsh; V Piranfar; S Rezaie
Journal:  Curr Med Mycol       Date:  2015-03

9.  Fusarium Solani: a causative agent of skin and nail infections.

Authors:  Thomas S Kuruvilla; Meena Dias
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

10.  Update on the treatment of disseminated fusariosis: Focus on voriconazole.

Authors:  Marta Stanzani; Fabio Tumietto; Nicola Vianelli; Michele Baccarani
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.